Annual information update
May 14 2007 - 12:24PM
UK Regulatory
RNS Number:5675W
Hikma Pharmaceuticals Plc
14 May 2007
Annual Information Update
LONDON, 14 May 2007. In accordance with Prospectus Rule 5.2, Hikma
Pharmaceuticals PLC ("Hikma" or "the Company")(LSE: HIK) (DIFX: HIK) sets out
below a summary of the information which has been published or made available to
the public over the previous 12 months. The information referred to in this
Update was up to date at the time the information was published, but some
information may now be out of date.
Stock Exchange announcements
Announcements made by the Company via RNS, a Regulatory Information Service, may
be viewed and downloaded from the London Stock Exchange website (
www.londonstockexchange.com/marketnews) or from the press releases page on the
Company's website at (http://investors.hikma.com/hikma/regulatorynews.jsp). The
London Stock Exchange announcements made during the defined period are:
Date of announcement Headline of announcement
23 Apr 07 Hikma appoints new CEO
20 Apr 07 Hikma acquires Thymoorgan
05 Apr 07 Block Listing 6-month review
05 Apr 07 Notification of transaction
03 Apr 07 LTIP awards
03 Apr 07 Notification of transaction
03 Apr 07 Notification of transaction
03 Apr 07 Notification of transaction
03 Apr 07 Notification of transaction
03 Apr 07 Notification of transaction
02 Apr 07 Notification of transaction
02 Apr 07 Notification of transaction
02 Apr 07 Notification of transaction
02 Apr 07 Voting rights and capital
23 Mar 07 Interest in shares
22 Mar 07 Final Results - Part 3
22 Mar 07 Final Results - Part 2
22 Mar 07 Final Results - Part 1
26 Jan 07 Completion of Acquisition
22 Jan 07 Hikma enters oncology market
18 Jan 07 Pre-close Trading Statement
21 Dec 06 Voting rights and capital
12 Dec 06 New board appointment
06 Dec 06 Director's Commitments
27 Nov 06 Notification of Transaction
22 Nov 06 Renewal of Contract
20 Nov 06 Notification of Site Visit
08 Nov 06 Notification of transaction
03 Nov 06 Section 198 Notification
27 Oct 06 Section 198 Notification
24 Oct 06 Trading update
09 Oct 06 Block Listing 6-month review
03 Oct 06 Notification of transaction
13 Sep 06 Interim Results 2006 - Part 1
13 Sep 06 Interim Results 2006 - Part 3
13 Sep 06 Interim Results 2006 - Part 2
11 Sep 06 Completion of Acquisition
13 Jul 06 Section 198 Notification
13 Jul 06 Pre-close Statement
21 Jun 06 Director Transaction
12 Jun 06 Section 198 Notification
31 May 06 Director Transaction
25 May 06 Results of AGM
25 May 06 AGM Trading Statement
24 May 06 Section 198 Notification
10 May 06 Hikma releases info on DIFX
27 Apr 06 Director/PDMR Shareholding
All of the above announcements were also made by the Company via the Dubai
International Financial Exchange ("DIFX") CANDI system. These announcements may
be viewed and downloaded from the DIFX website (www.difx.ae). Additional DIFX
announcements made during the defined period are:
26 Apr 2007 Notice of Annual Report and Accounts
Documents filed with the Financial Services Authority
The company has filed the following documents with the Financial Services
Authority ("FSA") over the previous 12 months. These documents are or will be
available to be viewed via the FSA's Document Viewing Facility or at the
Company's registered office.
Date filed with the FSA Document filed with the FSA
26 Apr 2007 2006 Annual Report and Accounts
26 Apr 2007 Notice of Annual General Meeting
Documents filed with Companies House
The Company has made the following filings with Companies House. Copies of these
documents may be obtained from Companies House, Crown Way, Maindy, Cardiff CF14
3UZ or, if you are a registered user, they may be viewed and downloaded using
Companies House Direct at www.direct.companieshouse.gov.uk. The Companies House
filings made during the defined period are:
Date filed with Companies Document filed with Companies House
House
3 May 2007 2006 Annual Report and Accounts
18 Apr 2007 Form 88(2) - Return of Allotment of Shares
18 Apr 2007 Form 88(2) - Return of Allotment of Shares
18 Apr 2007 Form 88(2) - Return of Allotment of Shares
11 Apr 2007 Form 88(2) - Return of Allotment of Shares
7 Feb 2007 Form 88(2) - Return of Allotment of Shares
7 Feb 2007 Form 88(2) - Return of Allotment of Shares
4 Jan 2007 Form 288a - Appointment of Director
12 Oct 2006 Form 88(2) - Return of Allotment of Shares
27 Sep 2006 Form 363s - Annual Return
13 Sep 2006 Interim Unaudited Accounts
12 July 2006 Form 88(2) - Return of Allotment of Shares
12 July 2006 Form 88(2) - Return of Allotment of Shares
25 May 2006 Form 287 - Change of registered office
25 May 2006 Ordinary and special resolutions passed at
AGM
23 May 2006 2005 Annual Report and Accounts
17 May 2006 Form 88(2) - Return of Allotment of Shares
17 May 2006 Form 88(2) - Return of Allotment of Shares
Henry Knowles
Company Secretary
14 May 2007
- ENDS -
Enquiries:
Hikma Pharmaceuticals plc +44 20 7399 2760
Henry Knowles, Company Secretary
Susan Ringdal, Investor Relations Director
Brunswick Group LLP +44 20 7404 5959
Jon Coles / Justine McIlroy / Alex Tweed
Notes to Editors
About Hikma
Hikma Pharmaceuticals PLC is a multinational pharmaceutical group focused on
developing, manufacturing and marketing a broad range of both branded and
non-branded generic and in-licensed pharmaceutical products. Hikma's operations
are conducted through three businesses: Generic, Branded and Injectable
Pharmaceuticals. Hikma's operations are based principally in the Middle East
and North Africa ("MENA") region, the United States and Europe. In 2006, the
Group had revenue of $317 million and profit attributable to shareholders of
$55 million. At 31 December 2006, the Group had over 2,443 employees. For news
and other information, please visit www.hikma.com.
This information is provided by RNS
The company news service from the London Stock Exchange
END
AIUQZLFFDEBFBBV
Hikma Pharmaceuticals (LSE:HIK)
Historical Stock Chart
From Jun 2024 to Jul 2024
Hikma Pharmaceuticals (LSE:HIK)
Historical Stock Chart
From Jul 2023 to Jul 2024
